319 related articles for article (PubMed ID: 31487418)
41. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
[TBL] [Abstract][Full Text] [Related]
42. Ribosomal protein L6 promotes growth and cell cycle progression through upregulating cyclin E in gastric cancer cells.
Gou Y; Shi Y; Zhang Y; Nie Y; Wang J; Song J; Jin H; He L; Gao L; Qiao L; Wu K; Fan D
Biochem Biophys Res Commun; 2010 Mar; 393(4):788-93. PubMed ID: 20171175
[TBL] [Abstract][Full Text] [Related]
43. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression.
Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740
[TBL] [Abstract][Full Text] [Related]
44. Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression.
Garcia P; Leal P; Alvarez H; Brebi P; Ili C; Tapia O; Roa JC
Arch Pathol Lab Med; 2013 Feb; 137(2):245-50. PubMed ID: 23368866
[TBL] [Abstract][Full Text] [Related]
45. [The role of tissue factor pathway inhibitor-2 gene in gallbladder cancer].
Qin YY; Gong W; Weng MZ; Li JY; Quan ZW
Zhonghua Wai Ke Za Zhi; 2012 Dec; 50(12):1099-103. PubMed ID: 23336488
[TBL] [Abstract][Full Text] [Related]
46. RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57
Mei L; Shen C; Miao R; Wang JZ; Cao MD; Zhang YS; Shi LH; Zhao GH; Wang MH; Wu LS; Wei JF
Cell Death Dis; 2020 Apr; 11(4):270. PubMed ID: 32332707
[TBL] [Abstract][Full Text] [Related]
47. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
[TBL] [Abstract][Full Text] [Related]
48. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J
Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245
[TBL] [Abstract][Full Text] [Related]
49. CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the "ERK1/2 - AP-1" and "JNK - AP-1" pathways.
Hong H; He C; Zhu S; Zhang Y; Wang X; She F; Chen Y
J Exp Clin Cancer Res; 2016 Mar; 35():51. PubMed ID: 27009073
[TBL] [Abstract][Full Text] [Related]
50. NSUN2-mediated RNA m
Luo G; Xu W; Chen X; Wang S; Wang J; Dong F; Hu DN; Reinach PS; Yan D
Epigenetics; 2022 Aug; 17(8):922-933. PubMed ID: 35757999
[TBL] [Abstract][Full Text] [Related]
51. Expression of NOL1/NOP2/sun domain (Nsun) RNA methyltransferase family genes in early mouse embryogenesis.
Chi L; Delgado-Olguín P
Gene Expr Patterns; 2013 Dec; 13(8):319-27. PubMed ID: 23816522
[TBL] [Abstract][Full Text] [Related]
52. Lysine-specific demethylase 1 promotes tumorigenesis and predicts prognosis in gallbladder cancer.
Lian SX; Shao YB; Liu HB; He JY; Lu WQ; Zhang Y; Jiang Y; Zhu J
Oncotarget; 2015 Oct; 6(32):33065-76. PubMed ID: 26460616
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
[TBL] [Abstract][Full Text] [Related]
54. Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo.
Wang J; Yao Y; Ming Y; Shen S; Wu N; Liu J; Liu H; Suo T; Pan H; Zhang D; Ding K; Liu H
Sci Rep; 2016 Jun; 6():28833. PubMed ID: 27349455
[TBL] [Abstract][Full Text] [Related]
55. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
[TBL] [Abstract][Full Text] [Related]
56. Bcl-2 gene silencing by RNA interference inhibits the growth of the human gallbladder carcinoma cell line GBC-SD in vitro and in vivo.
Geng ZM; Zhang M; Pan XT; Wang L
Oncol Rep; 2013 Aug; 30(2):793-800. PubMed ID: 23784204
[TBL] [Abstract][Full Text] [Related]
57. Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.
Hirosawa T; Ishida M; Ishii K; Kanehara K; Kudo K; Ohnuma S; Kamei T; Motoi F; Naitoh T; Selaru FM; Unno M
PLoS One; 2018; 13(11):e0206643. PubMed ID: 30395583
[TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA DILC promotes the progression of gallbladder carcinoma.
Liang C; Yang P; Han T; Wang RY; Xing XL; Si AF; Ma QY; Chen Z; Li HY; Zhang B
Gene; 2019 Apr; 694():102-110. PubMed ID: 30716440
[TBL] [Abstract][Full Text] [Related]
59. Galectin-9: An anticancer molecule for gallbladder carcinoma.
Tadokoro T; Morishita A; Fujihara S; Iwama H; Niki T; Fujita K; Akashi E; Mimura S; Oura K; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Himoto T; Hirashima M; Masaki T
Int J Oncol; 2016 Mar; 48(3):1165-74. PubMed ID: 26797414
[TBL] [Abstract][Full Text] [Related]
60. RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.
Kim YA; Siddiqui T; Blaze J; Cosacak MI; Winters T; Kumar A; Tein E; Sproul AA; Teich AF; Bartolini F; Akbarian S; Kizil C; Hargus G; Santa-Maria I
Acta Neuropathol; 2023 Jan; 145(1):29-48. PubMed ID: 36357715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
